Amgen Inc.
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

Last updated:

Abstract:

The present invention provides MDM2 inhibitor compounds of Formula I, ##STR00001## wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Status:
Application
Type:

Utility

Filling date:

3 Aug 2020

Issue date:

17 Jun 2021